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Abstract
Background: Whether decreased physical functioning of patients with mitochondrial disease (MD) is related to altered body
composition or low protein intake needs clarification at the background of the nutrition state.Methods: In this 2-site cross-sectional
study, MD patients were age-, body mass index (BMI)–, and gender-matched to controls. Body composition was assessed by dual-
energy x-ray absorptiometry. Physical functioning was measured by handgrip strength, 6-minute walking test, 30-second sit-to-
stand test (30SCT), and 6-minutemastication test. Total daily protein intake was calculated by 3-day food records.Malnutrition was
assessed by Patient-Generated Subjective Global Assessment and theGlobal Leadership Initiative onMalnutrition (GLIM) criteria
and sarcopenia by the 2018 consensus. Data were analyzed using independent samples t-tests, Fisher exact test, and Spearman
and Pearson correlation coefficients. Results: Thirty-seven MD patients (42 ± 12 years, BMI: 23 ± 4 kg/m2, 59% females) and
37 matched controls were included. Handgrip strength was moderate, inversely related to fat mass index in both MD patients
and controls, whereas it correlated with fat-free mass index in controls solely. Protein intake was associated with muscle strength
(handgrip strength and 30SCT) in MD patients but not in controls. Twenty-seven MD patients (73%) were malnourished, and 5
(14%) were classified as sarcopenic.Conclusions:Muscle strength is related to body composition and protein intake inMD patients.
This, in combination with the high incidence of both malnutrition and sarcopenia, warrants individual nutrition assessment inMD
patients. (JPEN J Parenter Enteral Nutr. 2021;45:165–174)
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Clinical Relevancy Statement
Physical functioning is chronically impaired in adult pa-
tients with mitochondrial disease, implicating decreased
quality of life. Insights in the relation between protein
intake, body composition, and physical functioning in these
patients and the prevalence of malnutrition and sarcopenia
could help to improve patient care.
Introduction
Approximately 1 out of 5000 persons worldwide is
confronted with mitochondrial disease (MD),1 a genetic
neuromuscular chronic disorder causing intracellular
energy (adenosine triphosphate) shortage.1 As MD patients
experience a wide range of complaints, such as fatigue,
muscular weakness, gastrointestinal complaints, dysphagia,
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and exercise intolerance,2,3 treatment focuses on symptom
relief, securing physical functioning, and quality of life.2
Poor physical functioning is predicted by a body weight
that is either too low or too high,4-7 conditions that are fre-
quently observed in MD patients.8-12 Also, body composi-
tion is known to be an important factor in physical function-
ing in the general population as well as in neuromuscular
disorders in particular.6,7,13,14 Decreased physical function-
ing was related to an increased fat mass in patients with
myotonic dystrophy13 or with decreased muscle mass in pa-
tients with muscular dystrophy.6,7,15 In patients with chronic
symptoms similar to MD, like kidney disease,16 lower fat-
free mass and decreased muscle strength were associated.
An increased muscle mass and strength may also be related
to lower diabetes risk.17 Altered body composition in MD
patients has been reported,9,12 and higher skeletal muscle
mass index in these patients was correlated with higher
muscle strength.12 However, whether physical functioning is
related to fat mass has not been established yet.
It is known that physical activity improves physical
function and body composition.18 The decreased physical
activity in MD patients10 is likely to play a role in body
composition and physical functioning in these patients.
However, it is not known whether MD patients’ physical
functioning is decreased because of altered body composi-
tion and/or if this possibly is influenced by nutrition intake.
It is know that physical function in MD patients can be
improved by physical exercise19; therefore, exercise is part
of standard care in MD patients.20
The combination of low muscle mass and low mus-
cle strength seen in MD patients may be defined as
sarcopenia.21,22 Sarcopenia significantly reduces function-
ing, as well as survival.21,23 Therefore, it is relevant to know
whether sarcopenia is also present in MD patients in order
to adjust treatment accordingly.24
The low physical functioning in MD patients may also
be related to alterations in nutrition intake and nutrition
status. Recent observational studies suggested that MD
patients have inadequate protein intake and are at risk of
malnutrition.9,24-26 This could affect both body composition
and physical functioning. Diagnosing malnutrition in MD
patients is challenging.9,27 Standard screening tools aimed at
screening acute malnutrition are not applicable in MD pa-
tients, as these patients suffer from chronic malnutrition.24
Recent literature advises to perform nutrition assessment to
determine nutrition state in MD patients,9,24,26 but it is not
knownwhichmeasurements are valid or which cutoff values
should be applied.
The primary goal of this study is to explore the associa-
tion between physical functioning, protein intake, and body
composition in adult MD patients. Additionally, the preva-
lence of malnutrition and sarcopenia in thisMDpopulation
is assessed using various nutrition assessment tools. Finally,
the diagnostic accuracy of bioelectrical impedance analysis
(BIA) to determine body composition in MD patients was
tested.
Methods
In this 2-site, cross-sectional study, the associations between
physical functioning, protein intake, and body composition
were examined in MD patients compared with age-, body
mass index (BMI)–, and gender-matched controls. The
study protocol was approved by the ethics committee of the
Nijmegen-Arnhem region (NL58262.091.16/2016-2667).
Primary and Secondary End Points
The primary end point was the association between physical
functioning, protein intake and body composition in MD
patients. The secondary end point is the prevalence of
malnutrition and sarcopenia in MD patients.
Study Population
Genetically confirmed MD patients and healthy controls
were included if they (1) were ≥18 years of age and (2)
had signed informed consent. Controls were matched with
included MD patients for age (±5 years), BMI (±2 kg/m2),
and gender. Exclusion criteria were (1) a pacemaker or im-
plant, (2) pregnancy or lactation, (3) disordered hydration
status (edema, dehydration), (4) diagnosis of a (chronic)
disease interfering with the nutrition assessment, or (5)
acute illness and fever. Additionally, MD patients were
excluded in case of (1) non–genetically confirmed MD
diagnosis, (2) diagnosis of none myopathic MD phenotype,
or (3) unavailability of dual-energy x-ray absorptiometry
(DXA) and handgrip-strength data.
A sample size of 37 MD patients and 37 controls
was calculated using data of MD patients (n = 24) and
compared with the reference values of Dodds28 to show a
difference of physical functioning betweenMDpatients and
controls with a power of 0.80 and an α of 0.05 based on an
estimated dropout rate of 30%, using the handgrip strength
as primary outcome variable for physical functioning.
Data Collection
MD patients’ data were prospectively obtained from the
Radboudumc’s MD expertise center (Radboud Centre for
Mitochondrial Medicine [RCMM]) from March 2015 until
January 2017. MD patients were measured during a 4-day
multidisciplinary evaluation program (as usual care) in the
internal medicine ward. Controls were measured at the
Nutritional Assessment Lab of the HAN University of
Applied Sciences between August 2017 and July 2018.
Demographic and Disease Characteristics
Age (years) and gender were collected from electronic
records in MD patients or obtained at day of measurement
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in controls. In addition, MD patients’ genotype and pheno-
type as well as the presence of dysphagia or gastrointestinal
problems were registered.
Physical Functioning
Physical functioning was assessed according to the applica-
ble standard operating procedures using 4 tools relevant for
MD patients. Muscle strength was measured by handgrip
strength (kg)21,29 and 30-second sit-to-stand test (30SCT;
number of sit-to-stands).30 Endurance was measured by the
6-minute walk test (6MWT; meters)21,31 and the 6-minute
mastication test (6MMT; number of chew cycles).32
Anthropometry and Body Composition
Height (cm), weight (kg), andwaist circumference (cm) were
measured to the nearest 1 decimal point. Total fat mass (kg),
total appendicular skeletal muscle mass (kg), and regional
lean tissue mass (kg) were determined by whole-body DXA
(Radboudumc: Hologic, model Discovery A S/N 85606;
HAN: Hologic, model HorizonW S/N 200103).33 Fat mass,
appendicular skeletal muscle mass, and regional lean tissue
mass were normalized by dividing total mass (kg) by height
(m) squared into fat mass index (kg/m2), skeletal muscle
index (kg/m2), and regional lean tissue mass index (kg/m2),
respectively.
Additionally, BIA measurements were performed ac-
cording to clinical practice (Bodystat MDD 1500, 50 Hz).
Fat-free mass (kg) was calculated twice using (1) Kyle
formula,34 having the smallest standard error and highest
R2,34 and (2) Dey, being validated in the elderly.35
The diagnostic accuracy of the BIA was tested using the
DXA as the golden standard. The sensitivity and specificity
were determined using the cutoff point of <15 kg/m2 and
<17 kg/m2 for fat-free mass index in women and men,
respectively,36 and obesity as fat percentage >30% for
women and >25% for men.37
Nutrition Intake
Nutrition intake was assessed by either a 3-day food record
or, in case missing in clinic, a dietary history using the nu-
trition calculation program Madows. Mean energy (kcal/d)
and protein (g/kg body weight/d) intake were calculated.
Number of persons on a specific diet were registered.
Malnutrition and Sarcopenia
Malnutrition was assessed by Patient-Generated Subjective
Global Assessment (PG-SGA) (score of ≥4 was interpreted
as risk for malnutrition and ≥9 as malnourished)38 and
the global leadership initiative on malnutrition (GLIM)
criteria.29 Sarcopenia was classified using handgrip
strength. The cutoff point for 70-year-olds21 as well as
the actual age cutoff point for low handgrip strength28 was
applied, as the majority of MD patients are younger than
70 years. Sarcopenic obesity was diagnosed according to
Baumgartner.39
Data Management
Data were entered encoded in an online case report form
(Castor, CIWIT B.V., Amsterdam, the Netherlands) and
double-checked visually by 2 researchers.
Statistical Analysis
Data were reported as means ± SD, median and interquar-
tile range, or frequencies and percentage of the group or
total population, if applicable. Normal distribution of the
variables was assessed by Shapiro-Wilk tests. Differences
between MD patients and controls were tested using the
independent t-test or Mann-WhitneyU tests for continuous
variables and Pearson χ2 test or Fisher exact test for
categorical variables.
Pearson or Spearman correlation coefficients were deter-
mined to assess the relations between physical functioning,
(regional) body composition, and protein intake. Because
fat-free mass index and skeletal muscle mass index were
associated, only fat-free mass index was used in association
analysis. Statistical analyses were performed using SPSS
statistics (IBM Statistics 23). To correct for multiple testing,
P-values ≤ .02 were considered statistically significant for
all analyses.
Results
Thirty-seven MD patients and 37 matched controls (all
white) were included in this study (Figure 1). Mean age
was 42 ± 12 years, and 59% were female (Table 1). Despite
having similar BMI,MDpatients had a shorter stature com-
pared with controls. Compared with controls, MD patients
were on a (diabetes) diet and experienced gastrointestinal
problems or dysphagia more often. The majority of theMD
patients were diagnosed with the m.3243A>G mutation
(78%) (Table 2).
Physical Functioning
Physical functioning in MD patients was lower compared
with that of controls, based on all physical functioning tests
(Table 3).
Body Composition
Total appendicular skeletal muscle mass was lower in
MD patients compared with controls (P < .02) (Table 3),
whereas no differences in total body fat or muscle mass
were observed. Also, leg lean tissue mass index was lower
in MD patients compared with controls (Table 3).




37 age-, BMI-, and 
gender-matched
healthy controls
92 Controls signed up 
from August 2017 
to April 2018 
68 MD-patients in the 
mitostraat from 2015 
to January 2017
Screening
Excluded from analysis: 31 patients
1. No informed consent (n = 1)
2. No DXA (n = 13)
3. No genetically determined
mutation (n = 12)
4. LHON syndrome (n = 4)
5. Comorbidity interfering with
handgrip strength (n = 1)
Excluded from participation: 55 controls
1. No match (n = 40)
2. Exclusion criteria (n = 9)
3. Personal circumstances (n = 2)
4. No response (n = 2)
5. Canceled appointment (n = 2)
Inclusion
Figure 1. Screening flowchart of MD patients and controls in the DYNAMO study. BMI, body mass index; DXA, dual-energy
x-ray assessment; LHON, Leber’s hereditary optic neuropathy; MD, mitochondrial disease





(n = 37) P-value
Age, y (mean ± SD) 42 ± 13 42 ± 12 .84
Female (n/%) 22 (59%) 22 (59%)
BMI, kg/m
b








2 (5%) 0 (0%)
<20, kg/m
2
9 (24%) 4 (11%)
20–25, kg/m
2
20 (54%) 23 (62%)
25–30, kg/m
2
6 (16%) 10 (27%)
>30, kg/m
2
2 (5%) 0 (0%)
Weight, kg (mean ± SD) 66.6 ± 12.3 72.2 ± 8.9 .04
Weight loss
a
(n/%) 4 (11%) 2 (5%) .39
Height, cm (mean ± SD) 170.8 ± 1.0 176.4 ± 0.9 .01
Waist circumference, cm, (mean ± SD) 84.3 ± 11.5 81.8 ± 8.0 .30
High waist circumference
b
(n/%) 14 (38%) 12 (32%) .46
Diet (n/%) 25 (68%) 2 (5%) <.001
Gastrointestinal problems (n/%) 28 (76%) 5 (13.5%) <.001
Dysphagia (n/%) 18 (49%) 0 (0%) <.001
P-values ≤.02 (in bold) were considered significant.
BMI, body mass index; IQR, interquartile range; MD, mitochondrial disease.
aWeight loss according to Global Leadership Initiative on Malnutrition (GLIM) criteria: >5% within past 6 months or >10% beyond 6 months.29
bHigh waist circumference >94 cm (women) and >80 cm (men) according to World Health Organization (WHO) 2008.43
Association Between Physical Functioning and
Body Composition
Handgrip strength was increased with higher fat-free mass
index in controls (Pearson r = 0.67, P < .001) but not
in MD patients (Pearson r = 0.30, P = .08) (Figure 2A).
In all MD patients together, no significant association
between handgrip strength and skeletal muscle mass in-
dex was observed; however, a significant association for
the m.3243A>G mutation genotype subgroup (Spearman
r= 0.31,P= .06, and r= 0.44,P< .02, respectively) was ob-
served (Table S1). Handgrip strength declined in both MD
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Table 2. Disease Characteristics of Mitochondrial Disease








Point mutations (mtDNA) 5 14
nDNA mutation 2 5
Deletion mtDNA 1 3
Phenotype




Leigh syndrome 2 5
MERRF 1 3
CPEO, chronic progressive external ophthalmoplegia; MELAS,
mitochondrial encephalomyopathy, lactic acidosis, and stroke-like
episodes; MERRF, myoclonus epilepsy with ragged-red fibers;
MIDD, maternally inherited diabetes and deafness; mtDNA,
mitochondrial DNA; nDNA, nuclear DNA.
patients and controls with higher fat mass index (Spearman
r= −0.61 and r= −0.49, respectively; P< .01) (Figure 2B).
Nutrition Intake
Energy intake was significantly lower in MD patients
compared with controls (Table 3). Moreover, significantly
more patients had an energy and protein intake below the
recommended intake (Table 3).
Association Between Physical Functioning and
Protein Intake
Protein intake was inversely correlated with fat mass
index in MD patients (Spearman r = −0.55, P < .01)
and controls (Spearman r = −0.39, P = .02) (Figure 2C).
Physical function was increased with higher protein intake
in MD patients, as measured by the 30SCT (r = 0.57,
P = .006) (Figure 2D) and handgrip strength (Spearman
r = 0.39, P = .02) (Table S2), but not in controls.
Other Associations
Protein intake and handgrip strength correlated with
arm lean tissue mass index in MD patients and controls,
respectively (MD patients: Pearson r = 0.53, P < .01 and
controls: Pearson r = 0.81, P < .001). No correlations
were found between either the 6MWT or the 6MMT and
body composition inMD patients and controls. The 30SCT
correlated with fat mass index (r = 0.41, P = .01) but not
with fat-free mass index (r = 0.01, P = .96) in controls
solely. No correlations were found between the 30SCT
and 6MWT with leg lean tissue mass index. The 6MMT
correlated moderately with protein intake (Spearman
r = 0.45, P = .02) in MD patients (Table S2).
Malnutrition and Sarcopenia
According to the PG-SGA, 32 MD patients (86%) were
in need of a nutrition intervention, whereas this was only
the case in 2 controls (6%) (Table 3). According to the
GLIM criteria, 46% of theMDpatients weremalnourished,
whereas 43% were malnourished according to the PG-
SGA (Table 3). If the PG-SGA data were combined with
the GLIM data, 27 MD patients (73%) were classified as
malnourished. Sarcopenia was observed in 14% or 27%
of the MD patients using either the consensus criterion
or the actual age cutoff point for low handgrip strength,
respectively.
Diagnostic Accuracy of BIA vs the DXA
The BIA-derived fat-free mass formulas of both Kyle and
Dey show good correlation with DXA fat-free mass in
MD patients (Kyle r2 = 0.9, Dey r2 = 0.8) as well as in
controls (Kyle r2 = 0.94). BIA tends to overestimate fat-
free mass compared with DXA (mean difference = 1.8 kg,
P = .01; 95% CI, −3.8 to 7.4 kg). BIA sensitivity (66%)
and specificity (57%) to diagnose obesity are lower than
to diagnose malnutrition (sensitivity 77%, specificity 93%)
(Table S3).
Discussion
The main finding of this study is that muscle strength is
related with body composition and protein intake in MD
patients.
Hou et al (2019)12 found a positive correlation between
skeletal muscle mass index and muscle strength (r = 0.4),
which is consistent with our hypothesis but was not signif-
icant in our cohort; this may be due to smaller numbers.
However, a positive association between skeletal mass in-
dex and handgrip strength was found in the m.3243A>G
genotype subgroup (Table S1), and a moderate association
between handgrip strength and arm lean tissue mass index
was found.
Surprisingly, sarcopenia existed in MD patients only,
whereas no difference in muscle mass between MD patients
and controls was observed. This might imply that handgrip
strength and body composition are differently associated in
MD patients compared with controls. Our results confirm
a different association in fat-free mass index with handgrip
strength between controls (Pearson r = 0.67, P < .001) and
MD patients (Pearson r = 0.30, P = .08, Figure 2A).
A high prevalence of malnutrition in MD patients (73%)
was confirmed.9 According to the GLIM criteria, 46% of
the MD patients were malnourished, whereas 43% were
malnourished according to the PG-SGA (Table 3). This
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Table 3. Physical Functioning, Body Composition, Nutrition Intake, Malnutrition, and Sarcopenia in MD Patients and Controls.
Physical functioning, body composition, nutritional




(n = 37) P-value*
Physical functioning test
Handgrip strength, kg, (mean ± SD) 28 ± 10 43 ± 9 <.001
Too low handgrip strength
a
(n/%) 6 (16) 0 (0)
Too low handgrip strength
b
(n/%) 15 (41) 0 (0)
6MMT (n chewing cycles) (mean ± SD) 396 ± 130 (n = 29) 577 ± 141 (n = 36) <001
30SCT (n sit-to-stands) (mean ± SD) 12 ± 4 (n = 22) 17 ± 4 (n = 36) <.001
6MWT (distance in m) (median; IQR) 441: 426–427 (n = 20) 681: 635–639 <.001
6MWT < 400 m (n/%) 3 (15) 0 (0)
Total body composition
FMI, kg/m2, (median; IQR) 7.7: 6.7–8.7 7.0: 6.3–7.7 .25
Fat percentage (%) (mean ± SD) 22 ± 7 16 ± 7 .21
High fat percentage
c
(n/%) 9 (24) 7 (19) .21
ASM, kg, (mean ± SD) 17.6 ± 4.0 19.8 ± 3.8 .02
FFMI, kg/m2, (mean ± SD) 15.2 ± 1.9 15.5 ± 1.6 .38
SMI, kg/m2, (mean ± SD) 6.0 ± 1.0 6.3 ± 0.9 .11
Too low SMI
d
(n/%) 25 (68) 21 (57) .34
Bone density, g/cm2, (mean ± SD) 0.31 ± 0.83 0.27 ± 0.80 .99
Osteopenia
e
(n/%) 3 (8) 0 (0) .08
Regional LTMI, kg/m2, (mean ± SD)
Average arm 1.3 ± 0.30 1.3 ± 0.3 .42
Trunk 12.7 ± 2.0 13.1 ± 1.5 .34
Average leg 3.8 ± 0.7 4.3 ± 0.6 .004
Nutrition intake
Protein intake, g/kg/d, (median; IQR) 1.1: 0.9–1.4 1.2: 1.1–1.7 .07
Too low protein intake
f
(n/%) 25 (68%) 4 (12%) <.01
Energy, kcal/d 1663 ± 500 2322 ± 644 <.001
Energy intake (% of calculated needs, mean ± SD) 81% ± 23.8% 98% ± 25.1% .03
Too low energy intake
g






0–4 (n/%) 5 (14%) 35 (95%)
PG-SGA
h
4–9 (n/%) 16 (43%) 1 (3%)
PG-SGA
h ≥9 (n/%) 16 (43%) 1 (3%)
Malnutrition
i
(n/%) 17 (46%) 10 (27%) .09
Severe malnutrition
i
(n/%) 1 (3%) 0 (0%)
Sarcopenia
j
(n/%) 5 (14%) 0 (0%) .02
Sarcopenic obesity
k
(n/%) 4 (11%) 3 (8%) .7
30SCT, 30-second sit-to-stand test; 6MMT, 6-minute mastication test; 6MWT, 6-minute walk test; ASM, appendicular muscle mass; FFMI,
fat-free mass index; FMI, fat mass index; GLIM, Global Leadership Initiative on Malnutrition; IQR, interquartile range; LTMI, lean tissue mass
index; PG-SGA, Patient-Generated Subjective Global Assessment; SMI, skeletal muscle index.
∗P-values ≤. 02 (in bold) were considered significant.
a
Too low handgrip strength = <16 kg for women and <27 kg for men based on Dodds reference at age 7028 according to the sarcopenia
consensus 2018.22
b
Too low handgrip strength based on Dodds reference29 according to actual age.22
c
High fat percentage according to the sarcopenic obesity criteria of Baumgartner = >28% for men and >40% for women.40
d
Too low SMI <7 kg/m2 for men and <6 kg/m2 for women according to the recommendations from European Working Group on Sarcopenia in
Older People 2 (EWGSOP2).22,30
e
Ostopenia = t-score between −1 and −2.5.
f
Too low protein intake = <1.2 g/kg/d for MD patients at risk for malnutrition = PG-SGA ≥4 and/or malnutrition according to GLIM criteria
(n = 34; 92% off MD patients) and 0.8 g/kg/d for controls and MD patients not at risk for malnutrition.
g
Too low energy intake <90% of calculated energy needs = resting energy expenditure according to the Harris and Benedict formula (1984) and
an activity factor of 1.4 for mobile MD patients, 1.2 for immobile MD patients, and 1.5 for controls.10
h
PG-SGA: 0–1 does not require nutrition input, 2–3 requires nutrition education, 4–8 requires specialized nutrition intervention, ≥9 indicates in
critical need of symptom management together with specialized nutrition intervention/malnutrition.39
i
Malnutrition and severe malnutrition according to GLIM criteria.30
j
Sarcopenia according to 2018 consensus.22
k
Sarcopenic obesity according to Baumgartner40 low SMI and high fat percentage.
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P < .001 P < .001
P < .001P < .001
Figure 2. Association between HGS, 30SCT, fat mass index, fat-free mass index, and protein intake. P-values < .02 (in bold) were










PG SGA ≥ 9
Figure 3. Venn diagram malnutrition according to GLIM
criteria and PG-SGA score ≥ 9 and Sarcopenia consensus
2018. GLIM, Global Leadership Initiative on Malnutrition;
PG-SGA, Patient-Generated Subjective Global Assessment.
seems to be a consistent result; however, Figure 3 shows
low comparability in malnutrition between the 2 methods.
A better comparability was seen between sarcopenia and
malnutrition because all patients diagnosed with sarcopenia
were also classified as malnourished (Figure 3). This low
comparability underlines the challenges of diagnosing mal-
nutrition and the conclusions of Aubry et al (2017)9 that
nutrition assessment should be part of patient care in all
adultMD patients. For measuring body composition, DXA
should be preferably used instead of BIA because of the
higher accuracy. For physical functioning, it is advisable to
measure handgrip strength and use the actual age cutoff
point of the Dodds reference.28 The incidence of sarcopenia
with this actual age cutoff point (27%) is very similar to
the results of Hou et al (2019),12 who observed sarcopenia
in 24.7% of the MD patients. The risk for malnutrition
according to the PG-SGA is higher in the current study
compared with the slightly overlapping cohort from the
DINAMITE study26—89% vs 55%. TheDINAMITE study
cohort consisted of outpatients, whereas the DYNAMO
study cohort was more severely affected, which justified a
4-day hospital admission. According to Hou et al,12 body
composition is a sensitive biomarker of disease severity
in MD patients. As low muscle mass is an indicator for
malnutrition, the difference in malnutrition risk observed in
the 2 studies is probably due to differences in disease severity.
The observed decreased physical functioning in MD
patients confirms previous studies.12
Except for lower stature, lower appendicular skeletal
muscle mass, and lower leg lean tissue mass index, body
composition in MD patients was not different compared
with that of controls. Although not significant and less
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profound, our data showed a trend toward higher fat mass
and lower lean mass in MD patients, which is similar to
other studies.9,12 In the study by Aubry et al (2017),9 MD
patients had higher BMI with comparable weight than MD
patients had in the current study. Moreover, their MD-
patient group consisted of more males and had a higher
mean age compared with that of the current study.9 As
height and body composition are known to be gender- and
age-related,7,13 this may have contributed to the (larger)
difference in body composition observed in the study of
Aubry et al (2017).9 When comparing the individual MD
patients’ and controls’ body composition in the current
study with reference values,40 a low skeletal muscle index in
bothMD patients and controls (68% vs 57%) was observed.
This result was anticipated for the MD patients, but not for
the controls, and might indicate that either the controls do
not represent a healthy status of body composition or the
reference data are not representative for the healthy Dutch
population.
A lower protein intake (g/kg/d) could not be confirmed
inMD patients compared with controls (P= .07). However,
relative to their protein needs, more MD patients have a
protein intake that is too low (68%) compared with that of
controls (12%).
The matched-control design, together with the accurate
measurement of whole and regional body composition
using DXA, is a strength of this study. The small study
sample size is a shortcoming. However, taking into account
the low prevalence of MD, a total of 37 MD patients is
considerable.
Data collection bias may have occurred because multiple
professionals performed the measurements, although stan-
dard operating procedures have been applied. Validity of
the DXA measurements may be influenced by the use of
2 scanners. However, that the body composition was not
different in MD patients compared with controls could not
be explained by this, because the body composition mea-
sured by BIA confirms that there was no difference between
body composition in MD patients compared with controls
(Table S3). Furthermore, underreporting or overreporting
of nutrition intake might have occurred.
Causal relationships could not be established in this
study. The associations observed were moderate at best,
indicating confounding or influencing factors. Handgrip
strength is known to be dependent by physical strength
exercise, and also, gender and age play a big role.41 Gender
and age cannot be changed, but exercise and nutrition intake
is something that can be influenced.
Although fat mass did not differ between MD patients
and controls, MD patients frequently have a high fat per-
centage (24%, Table 3) and high waist circumference (38%,
Table 1). As patients with neuromuscular disease are at
risk for developing metabolic syndrome,42 monitoring body
composition is recommended. If DXA is not available, and
because BIA has low sensitivity and specificity of diagnos-
ing high fat percentage (Table S3), waist circumference in
MD patients is the preferred method. Nutrition strategies
aiming at improving physical functionality and preventing
metabolic syndrome are recommended. Improving protein
intake seems a good start because a positive moderate
association between protein and muscle strength was found
as well as a moderate negative association between fat
mass and protein intake. Prospective intervention studies
are recommended to investigate whether adjusting protein
intake may improve functioning and muscle mass.
Conclusion
In conclusion, MD patients have decreased physical func-
tioning. There is a moderate inverse association between
handgrip strength and fat mass index in MD patients
and controls, between handgrip strength and fat-free mass
index in controls only, and between protein intake and
muscle strengths in MD patients only. This, in combina-
tion with the high prevalence of both malnutrition and
sarcopenia, warrants nutrition assessment in MD patients.
Future intervention studies on improving protein intake are
recommended.
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